Literature DB >> 19265237

Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.

Ramazan Cetinkaya, Abdullah Uyanik, Rahsan Yildirim, Yusuf Bilen, Mustafa Keles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19265237

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN： 0019-5359


× No keyword cloud information.
  4 in total

1.  Rhabdomyolysis-induced acute renal failure following fenofibrate therapy: a case report and literature review.

Authors:  Ramazan Danis; Sami Akbulut; Sehmus Ozmen; Senay Arikan
Journal:  Case Rep Med       Date:  2010-07-25

2.  Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia.

Authors:  Kazuya Kato; Astushi Nagase; Minoru Matsuda; Yurina Kato; Kazuhiko Onodera; Takako Kawakami; Mineko Higuchi; Yoshiaki Iwasaki; Masahiko Taniguchi; Hiroyuki Furukawa
Journal:  Case Rep Gastroenterol       Date:  2011-08-27

3.  Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.

Authors:  Chamara Dalugama; Manoji Pathirage; S A M Kularatne
Journal:  J Med Case Rep       Date:  2018-05-22

Review 4.  Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.

Authors:  Dawei Wang; Yanqiu Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.